Timely detection and judicious therapeutic interventions, such as pan-retinal photocoagulation (PRP) and anti-vascular endothelial growth factor (VEGF) injections, have been demonstrated to mitigate the risk of vision loss attributable to diabetes by 50% to 70% (2–4). The gene discussed is VEGFA; the disease is diabetes mellitus.